Patents by Inventor Norma Selve

Norma Selve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of rotigotine for the treatment of depression
    Patent number: 8754119
    Abstract: The present invention relates to the use of rotigotine [(?)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol] and its prodrugs and pharmaceutically acceptable salts for producing a pharmaceutical agent for treating depression.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: June 17, 2014
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • Method for treating peripheral neuropathic pain
    Patent number: 8053476
    Abstract: The present invention concerns the use of compounds of the Formula (I) for treating different types of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary inflammatory osteoarthritic pain. The compounds show an antinociceptive profile and differ from classical analgesics like opioids and non-steroidal anti-inflammatory drugs (NSAIDs) and are useful as specific analgesics.
    Type: Grant
    Filed: August 21, 2006
    Date of Patent: November 8, 2011
    Assignee: UCB Pharma GmbH
    Inventor: Norma Selve
  • METHOD FOR TREATING TINNITUS AUREUM
    Publication number: 20110082211
    Abstract: A method is described for treating tinnitus aureum in a subject by administering to the subject a therapeutically effective amount of a compound as defined in Formula I herein, illustratively (R)-2-acetamido-N-benzyl-3-methoxypropionamide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 15, 2010
    Publication date: April 7, 2011
    Applicant: UCB PHARMA GMBH
    Inventor: Norma Selve
  • Method and composition for treating pain or tinnitus aureum
    Patent number: 7875652
    Abstract: The present invention concerns the novel use of compounds of the Formula I: for treating allodynia as major and unique pain symptom independent of the nature of an underlying disease, but that is often related to neuropathic pain or other different types of chronic or phantom pain.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: January 25, 2011
    Assignee: UCB Pharma GmbH
    Inventor: Norma Selve
  • METHOD FOR TREATING DIABETIC PERIPHERAL NEUROPATHIC PAIN
    Publication number: 20100099770
    Abstract: The present invention concerns the novel use of compounds of the Formula I: for treating allodynia as major and unique pain symptom independent of the nature of an underlying disease, but that is often related to neuropathic pain or other different types of chronic or phantom pain.
    Type: Application
    Filed: December 21, 2009
    Publication date: April 22, 2010
    Applicant: SCHWARZ PHARMA AG
    Inventor: Norma Selve
  • Derivatives of azaspiro compounds for the treatment of pain
    Patent number: 7282515
    Abstract: This invention relates to azaspiro compounds and their use as medications especially for the treatment of chronic, chronic-phlogistic and/or neuropathic pain. Compounds that lend themselves particularly well to the production of analgesics include 1,3-diazaspiro[4.5]decane-2,4-dion and 1,3-diazaspiro[4.5]decane-2,4-dithion.
    Type: Grant
    Filed: September 7, 2004
    Date of Patent: October 16, 2007
    Assignee: Schwarz Pharma AG
    Inventors: Claus Meese, Norma Selve, Dirk Schmidt
  • Use of rotigotine for the treatment of depression
    Publication number: 20070093546
    Abstract: The present invention relates to the use of rotigotine [(?)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol] and its prodrugs and pharmaceutically acceptable salts for producing a pharmaceutical agent for treating depression.
    Type: Application
    Filed: July 22, 2004
    Publication date: April 26, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • Substituted 2-aminotetralin for the treatment of depression
    Publication number: 20070072917
    Abstract: The invention relates to the use of a compound of general formula (I) and the pharmaceutically acceptable salts, racemates or pure enantiomers thereof for the production of a medicament used to treat depression. The substituents are defined as in the description.
    Type: Application
    Filed: July 22, 2004
    Publication date: March 29, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • Method for treating acute or chronic pain
    Publication number: 20070054962
    Abstract: The present invention concerns the use of compounds of the Formula (I) for treating different types of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary inflammatory osteoarthritic pain. The compounds show an antinociceptive profile and differ from classical analgesics like opioids and non-steroidal anti-inflammatory drugs NSAIDs) and are useful as specific analgesics.
    Type: Application
    Filed: August 21, 2006
    Publication date: March 8, 2007
    Inventor: Norma Selve
  • Azaspiro compounds for the treatment of pain
    Publication number: 20050288351
    Abstract: This invention relates to azaspiro compounds and their use as medications especially for the treatment of chronic, chronic-phlogistic and/or neuropathic pain. A compound that lends itself particularly well to the production of analgesics is 2-azaspiro[4.6]undecane-3-thion.
    Type: Application
    Filed: September 7, 2004
    Publication date: December 29, 2005
    Applicant: Schwarz Pharma AG
    Inventors: Claus Meese, Norma Selve, Dirk Schmidt
  • Derivatives of azaspiro compounds for the treatment of pain
    Publication number: 20050119319
    Abstract: This invention relates to azaspiro compounds and their use as medications especially for the treatment of chronic, chronic-phlogistic and/or neuropathic pain. Compounds that lend themselves particularly well to the production of analgesics include 1,3-diazaspiro[4.5]decane-2,4-dion and 1,3-diazaspiro[4.5]decane-2,4-dithion.
    Type: Application
    Filed: September 7, 2004
    Publication date: June 2, 2005
    Applicant: Schwarz Pharma AG
    Inventors: Claus Meese, Norma Selve, Dirk Schmidt
  • Novel use of a peptide class of compound for treating non neuropathic inflammatory pain
    Publication number: 20050085423
    Abstract: The present invention concerns the use of compounds of the Formula (I) for treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary inflammatory osteoarthritic pain. The compounds show an antinociceptive profile and differ from classical analgesics like opioids and non-steroidal anti-inflammatory drugs (NSAIDS) and are useful as specific analgesics.
    Type: Application
    Filed: October 8, 2004
    Publication date: April 21, 2005
    Inventor: Norma Selve
  • Use of peptide class of compound for treating non neuropathic inflammatory pain
    Patent number: 6803481
    Abstract: The present invention concerns the use of compounds of the Formula (I) for treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary inflammatory osteoarthritic pain. The compounds show an antinociceptive profile and differ from classical analgesics like opioids and non-steroidal anti-inflammatory drugs (NSAIDS) and are useful as specific analgesics.
    Type: Grant
    Filed: February 11, 2003
    Date of Patent: October 12, 2004
    Assignee: Schwarz Pharma AG
    Inventor: Norma Selve
  • Novel use of peptide class of compound for treating non neuropathic inflammatory pain
    Publication number: 20030171300
    Abstract: The present invention concerns the use of compounds of the Formula (I) for treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary inflammatory osteoarthritic pain. The compounds show an antinociceptive profile and differ from classical analgesics like opioids and non-steroidal anti-inflammatory drugs (NSAIDS) and are useful as specific analgesics.
    Type: Application
    Filed: February 11, 2003
    Publication date: September 11, 2003
    Inventor: Norma Selve
  • Use of substituted 2,4-imidazolidinedione compounds as analgesics
    Patent number: 6022875
    Abstract: Disclosed in this invention is a method of analgesic treatment comprising administering an effective analgesic amount of a substituted 2,4-imidazolidinedione compound.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: February 8, 2000
    Assignee: Gruenenthal GmbH
    Inventors: Oswald Zimmer, Norma Selve
  • 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
    Patent number: 5733936
    Abstract: 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds, methods of preparing them and the use of these compounds in drugs are described.
    Type: Grant
    Filed: July 10, 1996
    Date of Patent: March 31, 1998
    Assignee: Gruenenthal GmbH
    Inventors: Helmut Heinrich Buschmann, Wolfgang Werner Alfred Strassburger, Norma Selve, Elmar Josef Friderichs
  • 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
    Patent number: RE37355
    Abstract: 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds, methods of preparing them and the use of these compounds in drugs are described.
    Type: Grant
    Filed: March 30, 2000
    Date of Patent: September 4, 2001
    Assignee: Gruenenthal GmbH
    Inventors: Helmut Heinrich Buschmann, Wolfgang Werner Alfred Strassburger, Norma Selve, Elmar Josef Friderichs